eBooks Press Release -- NEWS
Anti-Angiogenesis Drug Discovery and Development, Now in its 4th Edition
News Release Date: July 16, 2019
This eBook is edited by Dr. Atta-ur-Rahman, FRS and Prof. Dr. M. Iqbal Choudhary on June 10, 2019.
Bentham Science ongoing book series continues to bring more updates anti-angiogenesis drug targets. This volume brings together 7 reviews on the following topics: Retinal angiogenesis in diabetes and macular degenerative processes; the effects of brief daily EMF therapy on tumor growths in hypoxia induced cancers in mice; reviews of anti-angiogenic cancer treatments over the last few decades; anti-angiogenic therapies for multiple sclerosis; and an update on the link between angiogenesis and portal hypertension. The volume is interesting reading for pharmacologists and clinicians interested in the role of angiogenesis and associated treatments in oncology, ophthalmology and neurology.
About The Editors:
Prof. Dr. Atta-ur-Rahman
Atta-ur-Rahman, Ph.D. in organic chemistry from Cambridge University (1968), has 1142 international publications in several fields of organic chemistry including 775 research publications, 43 international patents, 70 chapters in books and 256 books published largely by major U.S. and European presses. He is the Editor-in-Chief of eight European Chemistry journals. He is Editor of the world's leading encyclopedic series of volumes on natural products "Studies in Natural Product Chemistry" 60 volumes of which have been published under his Editorship by Elsevier during the last two decades.
M. Iqbal Choudhary
M. Iqbal Choudhary is a Ph. D. scientist in the field of organic chemistry from Pakistan working at the University of Karachi. He is known for his research in bioorganic chemistry and natural product chemistry. He has more than 900 research publications, including 33 books published.
Keywords: Quizartinib, chemotherapy, Gastrointestinal cancer, breast cancer, Long Non-Coding RNAs, Apoptosis, breast cancer, Tyrosine Kinase Inhibitors